Radiotherapy Market: Continuous investments to develop advanced and compact radiotherapy platforms to drive global demand for external beam radiotherapy segment
The global radiotherapy
market is segmented on the basis of type, product type,
application, end user and region. Based on type, the radiotherapy market is
segmented into external beam radiotherapy, internal beam
radiotherapy/brachytherapy, and systemic radiotherapy. On the basis of type,
the external beam radiotherapy segment is further divided into
intensity-modulated radiotherapy, image-guided radiotherapy, tomotherapy,
stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and
volumetric modulated arc therapy. The internal beam radiotherapy segment is
divided into low-dose-rate brachytherapy and high-dose-rate brachytherapy. The
systemic radiotherapy segment is divided into oral, intravenous, and
instillation radiotherapy. The image-guided radiotherapy segment accounted for
the largest share of the radiotherapy market. The large share of this segment
can be attributed to the advantages offered by image-guided radiotherapy such
as high precision, good quality image guidance, and the use of higher radiation
dose.
The global radiotherapy market is projected to reach USD 9.47 billion by 2022 at a CAGR of 6.8% during forecast period. Technological advancements in the field of radiotherapy and rising incidence of cancer are the major factors driving the growth of the global radiotherapy market. Additionally, rapid growth in the aging population, growing adoption of radiotherapy for the treatment of cancer, and increasing number of conferences and symposia focusing on the advancements in radiotherapy are some of the other factors driving the growth of this market. In addition, emerging markets (such as China and India) are poised to offer new growth opportunities for key radiotherapy market players during the next decade.
Download Free Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=567
External beam radiation therapy involves the use of a high energy beam from an external source targeted at the tumor site.
In 2016, the External beam radiation therapy segment accounted for a share of 91.2% of the radiotherapy market. The growth in this segment is attributed to factors such as; rising adoption of linear accelerators for the treatment of cancer and development of advanced radiotherapy technologies; development of compact advanced radiotherapy systems such as CyberKnife, Gamma Knife; increasing R&D programs; the expanding applications of these devices; and Technological developments in terms of enhanced patient comfort, superior beam focusing, easy-of-use, and affordability to patients are driving growth.
As of 2015, Varian Medical Systems, Inc. (US) held the leadership position in the global radiotherapy market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements; strategic acquisitions and agreements as its key business strategies to ensure its global dominance in this market.
The other key players in the market include Varian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), IBA (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (US), Isoray Medical, Inc. (US), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (US), Mitsubishi Electric Corporation (Japan), among others.
Medical Devices Market Research Reports & Consulting
The global radiotherapy market is projected to reach USD 9.47 billion by 2022 at a CAGR of 6.8% during forecast period. Technological advancements in the field of radiotherapy and rising incidence of cancer are the major factors driving the growth of the global radiotherapy market. Additionally, rapid growth in the aging population, growing adoption of radiotherapy for the treatment of cancer, and increasing number of conferences and symposia focusing on the advancements in radiotherapy are some of the other factors driving the growth of this market. In addition, emerging markets (such as China and India) are poised to offer new growth opportunities for key radiotherapy market players during the next decade.
Download Free Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=567
External beam radiation therapy involves the use of a high energy beam from an external source targeted at the tumor site.
In 2016, the External beam radiation therapy segment accounted for a share of 91.2% of the radiotherapy market. The growth in this segment is attributed to factors such as; rising adoption of linear accelerators for the treatment of cancer and development of advanced radiotherapy technologies; development of compact advanced radiotherapy systems such as CyberKnife, Gamma Knife; increasing R&D programs; the expanding applications of these devices; and Technological developments in terms of enhanced patient comfort, superior beam focusing, easy-of-use, and affordability to patients are driving growth.
As of 2015, Varian Medical Systems, Inc. (US) held the leadership position in the global radiotherapy market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements; strategic acquisitions and agreements as its key business strategies to ensure its global dominance in this market.
The other key players in the market include Varian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), IBA (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (US), Isoray Medical, Inc. (US), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (US), Mitsubishi Electric Corporation (Japan), among others.
Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.comResearch Insight: https://www.marketsandmarkets.com/ResearchInsight/radiotherapy-monitoring-devices-market.asp
Comments
Post a Comment